• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将协变量调整与成组序贯、信息自适应设计相结合以提高随机试验效率。

Combining covariate adjustment with group sequential, information-adaptive designs to improve randomized trial efficiency.

作者信息

Van Lancker Kelly, Betz Joshua F, Rosenblum Michael

机构信息

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States.

Department of Mathematics, Computer Science and Statistics, Ghent University, Ghent 9000, Belgium.

出版信息

Biometrics. 2025 Jan 7;81(1). doi: 10.1093/biomtc/ujaf020.

DOI:10.1093/biomtc/ujaf020
PMID:40063405
Abstract

Group sequential designs (GSDs), which involve preplanned interim analyses that allow for early stopping for efficacy or futility, are commonly used for ethical and efficiency reasons. Covariate adjustment, which involves appropriately adjusting for prespecified prognostic baseline variables, can improve precision and is generally recommended by regulators. Combining these, that is, using adjusted estimators at interim and final analyses of a GSD, has potential for dual benefits. We address 2 challenges involved in combining these methods. First, adjusted estimators may lack the independent increments structure (asymptotically) that is required to directly apply standard stopping boundaries for GSDs. We address this by applying a linear transformation to the sequence of adjusted estimators across analysis times, resulting in a new sequence of consistent, asymptotically normal estimators with the independent increments property that either improves or leaves precision unchanged. This approach generalizes foundational results on GSDs with semiparametric efficient estimators to any sequence of regular, asymptotically linear estimators. Second, we address the practical problem of handling uncertainty about how much (if any) precision gain will result from covariate adjustment. This is important for trial planning, since an incorrect projection of a covariate's prognostic value risks an over- or underpowered trial. We propose using information-adaptive designs, that is, continuing the trial until the required information level is achieved. This design enables faster, more efficient trials, without sacrificing validity or power.

摘要

成组序贯设计(GSDs)出于伦理和效率原因通常被采用,该设计涉及预先计划好的期中分析,允许基于疗效或无效性提前终止试验。协变量调整,即对预先指定的预后基线变量进行适当调整,可以提高精度,并且通常受到监管机构的推荐。将这两者结合起来,即在GSD的期中分析和最终分析中使用调整后的估计量,可能会带来双重益处。我们解决了结合这些方法所涉及的两个挑战。首先,调整后的估计量可能缺乏(渐近地)直接应用GSD标准停止边界所需的独立增量结构。我们通过对跨分析时间的调整后估计量序列应用线性变换来解决这个问题,从而得到一个具有独立增量性质的新的一致、渐近正态估计量序列,该序列要么提高精度,要么保持精度不变。这种方法将关于具有半参数有效估计量的GSD的基础结果推广到任何正则、渐近线性估计量序列。其次,我们解决了处理协变量调整将带来多少(如果有的话)精度增益的不确定性这一实际问题。这对于试验规划很重要,因为对协变量预后价值的错误预测会使试验面临效能过高或过低的风险。我们建议使用信息自适应设计,即持续试验直到达到所需的信息水平。这种设计能够实现更快、更高效的试验,同时不牺牲有效性或效能。

相似文献

1
Combining covariate adjustment with group sequential, information-adaptive designs to improve randomized trial efficiency.将协变量调整与成组序贯、信息自适应设计相结合以提高随机试验效率。
Biometrics. 2025 Jan 7;81(1). doi: 10.1093/biomtc/ujaf020.
2
Prognostic adjustment with efficient estimators to unbiasedly leverage historical data in randomized trials.使用有效估计量进行预后调整,以在随机试验中无偏地利用历史数据。
Int J Biostat. 2025 Mar 11;21(1):1-15. doi: 10.1515/ijb-2024-0018. eCollection 2025 May 1.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
Systemic Inflammatory Response Syndrome全身炎症反应综合征
7
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
8
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.